| Literature DB >> 26306321 |
Teresa Núñez de Villavicencio-Díaz1, Yassel Ramos Gómez1, Brizaida Oliva Argüelles2, Julio R Fernández Masso1, Arielis Rodríguez-Ulloa1, Yiliam Cruz García3, Osmany Guirola-Cruz1, Yasset Perez-Riverol4, Luis Javier González1, Inés Tiscornia5, Sabina Victoria5, Mariela Bollati-Fogolín5, Vladimir Besada Pérez1, Maribel Guerra Vallespi2.
Abstract
CIGB-552 is a second generation antitumor peptide that displays potent cytotoxicity in lung and colon cancer cells. The nuclear subproteome of HT-29 colon adenocarcinoma cells treated with CIGB-552 peptide was identified and analyzed [1]. This data article provides supporting evidence for the above analysis.Entities:
Keywords: Apoptosis; CIGB-552 synthetic peptide; Colorectal cancer; Enrichment analysis; Inflammation; Text mining
Year: 2015 PMID: 26306321 PMCID: PMC4534583 DOI: 10.1016/j.dib.2015.06.024
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1SDS-PAGE analysis of nuclear and PBS-Triton X-100 soluble fractions for both control and CIGB552-treated samples. Lanes 1,2: PBS-Triton X-100 soluble and nuclear fractions of control sample, experiment#1; Lanes 3,4: PBS-Triton X-100 soluble and nuclear fractions of CIGB552 peptide-treated, experiment#1; Lanes 5,6: PBS-Triton X-100 soluble and nuclear fractions of control sample, experiment#2; Lanes 7,8: PBS-Triton X-100 soluble and nuclear fractions of CIGB552 peptide-treated, experiment#2. The 12.5% T gel was silver stained according to standard procedures [12].
Fig. 2Schematic representation of DF-PAGE method for quantitative proteomics. Nuclear proteins from both, control and CIGB-552 peptide treated cells were fractionated by SDS-PAGE. Homologous fractions are in-gel digested with trypsin and further isotopically labeled with normal or deuterated N-acetoxy-succinimide. Samples from control and CIGB-552 peptide treated cells are mixed and fractionated by SDS-free PAGE. Collected fractions are then analyzed by LC-MS/MS.
Fig. 3SDS-PAGE analysis of nuclear fractions obtained from control and CIGB-552 peptide treated cells of two independent experiments. At the right side is shown a schematic representation of the device used for cutting the gel and obtaining the SDS-PAGE fractions. The 12.5% T gel was silver stained according to standard procedures [12]. C1, T1: control and CIGB-552 peptide treated samples from the experiment#1. C2, T2: control and CIGB-552 peptide treated samples from the experiment#2. The number and protein mass range of the fractions F1-6 are indicated at the right side of the figure.
Fig. 4Schematic representation of the subcellular location classification procedure that shows the number of identified/differentially modulated proteins classified as nuclear located.
Fig. 5Schematic representation of the bioinformatics-driven functional interpretation procedure to study the function of the differentially modulated proteins and the results obtained which derives in the experimental validation of specific biological processes and pathways.
Fig. 6Chilibot text mining analysis for identifying functional relationships between a set of differentially modulated proteins and between these proteins and cell adhesion and metastasis.
Specifications Table
| Subject area | Biology |
| More specific subject area | Pharmacology, Proteomics |
| Type of data | Figure, table, methods |
| How data was acquired | Mass spectrometry: hybrid quadrupole orthogonal acceleration tandem mass spectrometer QTof-2 (Micromass, Manchester, U.K.) |
| Data format | Analyzed |
| Experimental factors | Isolation of the Nuclear Proteins Enriched Fraction, trypsin digestion and isotope labeling of peptides |
| Experimental features | Subcellular fractionation, protein and peptide fractionation by DF-PAGE and LC-MS/MS peptide identification |
| Data source location | Havana, Cuba |
| Data accessibility | The data are provided in this article. |